DAY 1 THURSDAY MORNING, MARCH 18 

​​​​​

* All Meals are served in Salons 1-3 Adjacent to the Ballroom

* Ballroom – Location of all General Sessions – Main Floor of Hotel

* Presentations are 10 minutes each.​

​

6:30 – 7:45   Full Breakfast Provided  -- Salons 1-3

​

8:00 – 8:40   WELCOME FROM STAIR CO-CHAIRMEN  -- Ballroom

SETTING THE STAGE​

      Welcome to STAIR XIV - Co-chairs; Greg Albers and Marc Fisher

      "Targets for New Drug and Device Development" - Michael Hill

​

8:40 – 10:25    SESSION 1   WHAT HAVE WE LEARNED FROM RECENT ACTUE STROKE TRIALS?

Session Chairs:  Jim Grotta and Argye Hillis

• Lessons learned from Thrombolysis Trials – Carol Xiong

• Next Steps for Thrombectomy Trials – Jeremy Heit

• Status and Insights from cytoprotective Trials – Kevin Sheth​​

ROUNDTABLE PANEL DISCUSSION: Representatives from Industry and Academia

 

9:45 – 10:10       Refreshment Break  -- Foyer Outside of Ballroom

 

10:15 – 11:45   SESSION 2    ADJUNCTIVE THROMBOLYTIC AND CYTOPROTECTIVE THERAPY PRE/PERI/POST-EVT

Session Chairs:  Marc Ribo and Opeolu Adeoye

• Evolving Cytoprotective Strategies - Pat Lyden

• Thrombolytic Approaches, Personalized Blood Pressure Targeting – Enrique Leira

• Is No-Reflow a Viable Therapeutic Target?– Urs Fischer

• Role of Flat Panel Perfusion Imaging – Marios Psychogios​

ROUNDTABLE PANEL DISCUSSION: Representatives from Industry and Academia

 

11:45 – 12:45   LUNCH PROVIDED  -- Salons 1-3

 

DAY 1  THURSDAY AFTERNOON -- Ballroom  

 

1:00 – 2:30  SESSION 3  THE EXPANDING ROLE OF AI IN CLINICAL TRIALS, DIAGNOSIS AND MANAGEMENT

Session Chairs:  Ajay Wakhloo, David Liebersking

• AI Platforms in 2027 - Lee Schwamm

• AI and Robotics for Stroke Treatment – Santiago Ortega

• Advances in AI Diagnosis – Vivek Yedavalli

• Advances in Stroke Management with AI  – Joe Broderick​

ROUNDTABLE PANEL DISCUSSION:  Representatives from Industry and Academia

 

2:30 – 4:00   SESSION 4  THE FUTURE PREDICTIONS FOR 2037

Session Chairs: Shadi Yagi, Hooman Kamel

• Acute Management – Jeff Saver

• EVT Innovations – Raul Nogueira

• Stroke Imaging – Bruce Campbell

• Stroke Prevention – Askan Shoamanesh

ROUNDTABLE PANEL DISCUSSION: Representatives from Industry and Academia

​

4:00 – 4:20       Refreshment Break  -- Foyer Outside of Ballroom

 

4:20 – 5:30    SESSION 5  REGULATORY QUESTIONS AND NINDS UPDATES  

Session Chairs: Greg Albers and Wade Smith

• New Approaches at NINDS - Clinton Wright, NINDS Acting Director

• FDA - CDER & CDRH Regulator Leadership Address Stroke Community Questions

ROUNDTABLE PANEL DISCUSSION:  Representatives from Regulatory, Industry and Academia

 

6:30 – 7:30    SPONSORED RECEPTION -- Studio B – Main Floor of Hotel

 

7:30 – 9:00    DINNER BANQUET   -- Salons 1-3

FOLLOWED BY SPECIAL PRESENTATION AND DISCUSSION

 "HOW TO FUND FUTURE STROKE TRIALS - MOTIVATING INVESTORS AND CREATING PARTNERSHIPS"

- Chairs: Marc Fisher and Greg Albers -

- Panel: Industry and and Investment Company Representatives -

​

​​​

DAY 2  FRIDAY MORNING, MARCH 19 ​​​​

​

6:45 –7:45   FULL BREAKFAST PROVIDED  -- Salons 1-3

​​

​

8:00 – 10:30   WORKSHOPS TO DEVELOP RECOMMENDATIONS 

 * All Participants - Please Report Directly to Your Assigned Workshop at 8:00 AM 

 * All Workshops held in Studios B, D and F on Main Floor of Hotel​

 * Participants divide into three groups according to their topic choice

 * Each group will develop recommendations on their selected topic​

​

WORKSHOP 1:   COMBINING REPERFUSION WITH ADJUNCTIVE THERAPIES

​

Studio - D     Facilitators – Co-chairs: Pooja Khatri, Edgar Samaniego and Johannes Boltze

                  

WORKSHOP 2:   OPTIMIZING THE USE OF AI FOR STROKE RESEARCH AND MANAGEMENT

​

Studio - B     Facilitators – Co-chairs: Larry Wechsler, Maarten Lansberg and Paul Wechsler ​

​

WORKSHOP 3:   DESIGNING AND IMPLEMENTING THE STROKE TRIALS OF THE FUTURE

​

Studio - F      Facilitators – Co-Chairs: Eva Mistry, Jordan Elm and Johanna Ospel

​

10:30 – 10:45   Refreshment Break 

 

10:45 – 12:00    WORKSHOP CHAIRS PRESENT RECOMMENDATIONS TO FULL ASSEMBLY​

​

Ballroom        Drafting of consensus statements is initiated – Chaired by Greg Albers and Marc Fisher

​​​​

12:00 – 12:15      CLOSING COMMENTS AND ADJOURNMENT

​​​​​​

STAIR MISSION STATEMENT

The STAIR Consensus Conferences, via a collaboration of medical academia, the healthcare industry and government agencies, are intended to advance and accelerate stroke research to ultimately result in improved stroke acute treatment, care and prevention. To achieve this goal, STAIR will:

•   Develop new approaches to overcome barriers impeding stroke drug and device development

•   Identify, clarify and communicate the implications of new research to the stroke field

•   Publish STAIR Workshop recommendations developed by participants which address these concerns

•   Promote adoption of STAIR solutions by research, industry, clinical and government communities